Pharmacology Department Library
Room 1102, Mary Ellen Jones Building


PMT SEMINARS: 2001-2005



DATE
SPEAKER
SEMINAR TITLE
January 26, 2001
Friday, 12:00 noon
C. Frank Bennett, Ph.D.
Antisense Research
Isis Pharmaceuticals, Inc.
Contact: Rudy Juliano (966-4383)
Development of Antisense Oligonucleotides as Pharmaceuticals
February 23, 2001
Friday, 12:00 noon
Alan M. Gewirtz, M.D.
Stem Cell Biology and Therapeutics Program
University of Pennsylvania Cancer Center
Contact: Rudy Juliano (966-4383)
Rational Development of Nucleic Acid Therapeutics for Hematologic Malignancies
March 16, 2001
Friday, 12:00 noon
Leaf Huang, Ph.D.
Center for Pharmacogenetics
University of Pittsburgh
Contact: Rudy Juliano (966-4383)
Non-Viral Gene Therapy

February 8, 2002
Friday, 12:00 p.m.

Frank Szoka, Ph.D.
School of Pharmacy
University of California, San Francisco
Contact: Rudy Juliano (966-4383)
Liposomes – their rapid evolution from a model biomembrane to a targeted drug carrier
March 22, 2002
Friday, 12:00 p.m.
Dr. Lloyd Mitchell, Ph.D.
Intronn Inc.
Contact: Rudy Juliano (966-4383)
Gene Reprograming by SMaRT (Spliceosome Mediated RNA Trans-splicing)
March 29, 2002
Friday, 12:00 p.m.

Bruce Sullenger, Ph.D.
Duke University
Contact: Rudy Juliano (966-4383)
Nucleic acid aptamers
April 18, 2002
Thursday, 12:00 p.m.

Nick Dean, Ph.D.
Isis Pharmaceuticals, Inc.
Contact: Rudy Juliano (966-4383)
Progress in bringing antisense into the clinic
Jan 10, 2003
Thursday, 12:00 p.m.

Cy Stein, M.D.
Columbia University
Contact: Rudy Juliano (966-4383)
New concepts in antisense research
July 15, 2003
Tuesday, 12:00 noon
Steve Wilton, Ph.D.
Center for Neuromuscular and Neurological Disorders
University of Western Australia
Contact: Rudy Juliano (966-4383)
Both ends of molecular medicine: high throughput genotyping and redirection of gene expression using antisense oligonucleotides (Application to Muscular Dystrophy)
October 3, 2003
Friday, 12:00 noon
Carlos F. Barbas III, Ph.D.
Kellogg II Professor of Molecular Biology
Scripps Research Institute
Contact: Rudy Juliano (966-4383)
Polydactyl zinc finger transcription factors: designing and selecting regulators of endogenous genes
November 7, 2003
Friday, 12:00 noon
Scott Hammond, Ph.D.
Asst. Professor of Cell and Developmental Biology
UNC-CH
Contact: Rudy Juliano (966-4383)
RNAi, microRNAs, and human disease
December 17, 2003
Wednesday, 12:00 noon
Arthur Kreig, M.D.
Chief Scientific Officer
Coley Pharmaceutical Group
Contact: Rudy Juliano (966-4383)
Recognition of unmethylated CpG motifs in bacterial DNA by TLR9, and activation of immunity
April 2, 2004
Friday, 12:00 noon
Jacek Hawiger, M.D., Ph.D.
Oswald T. Avery Distinguished Chair of Microbiology & Immunology
Vanderbilt Uni Sch of Medicine
Contact: Rudy Juliano (966-4383)
Targeting of Functional Cargo Across Plasma Membrane
May 6, 2004
Thursday, 12:00 noon
Piet Herdewijn, Ph.D.
Director, Laboratory of Medicinal Chemistry
Faculty of Pharmaceutical Sciences
Katholieke Universiteit, Leuven, Belgium
Contact: Rudy Juliano (966-4383)
Structure and properties of modified oligonucleotides
November 16, 2004
Tuesday, 2:00 pm
Alexander Kabanov, Ph.D.
Parke-David Professor of Pharmaceutical Sciences
College of Pharmacy
University of Nebraska Medical Center
Contact: Rudy Juliano (966-4383)
Polymer genomics
November 29, 2004
Monday, 12:00 noon
Kam Leong, Ph.D.
Department of Biomedical Engineering
Johns Hopkins University School of Medicine
Contact: Rudy Juliano (966-4383)
Delivery of biologics from fibrous scaffolds

April 18, 2005

Monday, 4:00 p.m.

Michael Gait, Ph.D.
MRC Laboratory of Molecular Biology
Cambridge University

Contact: Rudy Juliano (966-4383)

Targeting HIV-1 RNA-protein interactions in cells with synthetic oligonucleotides and conjugates


PMT Home